奥特兹拉TM (阿普里米拉斯特30毫克片)
William Abramovits1,2, Aditya K Gupta3,4, Kimberly Dawn Vincent5
1Department of Medicine, Baylor Scott & White University Hospital, Dallas, TX.
Skinmed
|August 1, 2024
概括
艾普雷米拉斯特是一种口服固酶-4抑制剂,已被批准用于牛皮关节炎,斑块牛皮和贝赫特病. 本次审查审查了其在治疗其他未经批准的皮肤病症方面的潜力.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 奥特斯拉 (apremilast) 已批准用于治疗牛皮关节炎,斑块牛皮和贝赫特病.
- 阿普雷米拉斯特向基化酶-4 (PDE4),这是一个涉及炎症性皮肤疾病的酶.
- 现有的批准强调了阿普雷米拉斯特在特定皮肤病和自身免疫性疾病中的有效性.
研究的目的:
- 审查阿普雷米拉斯特的潜在治疗效用.
- 探索其在目前批准之外的皮肤学指示中的应用.
- 评估扩大阿普雷米拉斯特使用的科学理由.
主要方法:
- 关于阿普雷米拉斯的现有研究的文献综述.
- 对固-4抑制机制的分析.
- 在各种皮肤病症中对病变发生的评估.
主要成果:
- 阿普雷米拉斯特的作用机制表明它具有广泛的抗炎作用.
- 有证据支持其在其他炎症性皮肤病中的潜力.
- 对于未经批准的指示,需要进行进一步的临床研究.
结论:
- 阿普雷米拉斯特显示出治疗其他皮肤病的潜力.
- 它的固酶-4抑制作用与多种炎症性皮肤疾病有关.
- 扩大阿普雷米拉斯特的使用可能有利于那些有未满足需求的患者.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
268
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
268
Antiasthma Drugs: β2-Adrenoceptor Agonists
244
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
244
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
264
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
264
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Methylxanthines
214
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
214


